AAAAAA

   
Results: 1-10 |
Results: 10
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists
Authors: DiPardo, RM Patane, MA Newton, RC Price, RA Broten, TP Chang, RSL Ransom, RW Di Salvo, J Freidinger, RM Bock, MG
Citation: Rm. Dipardo et al., Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists, BIOORG MED, 11(14), 2001, pp. 1959-1962
Bradykinin antagonists: new opportunities
Authors: Bock, MG Longmore, J
Citation: Mg. Bock et J. Longmore, Bradykinin antagonists: new opportunities, CURR OP C B, 4(4), 2000, pp. 401-406
Determination of the relative and absolute stereochemistry of a potent andalpha(1A)-selective adrenoceptor antagonist
Authors: Lagu, B Wetzel, JM Forray, C Patane, MA Bock, MG
Citation: B. Lagu et al., Determination of the relative and absolute stereochemistry of a potent andalpha(1A)-selective adrenoceptor antagonist, BIOORG MED, 10(24), 2000, pp. 2705-2707
Phenylacetamides as selective alpha-1A adrenergic receptor antagonists
Authors: Patane, MA DiPardo, RM Newton, RC Price, RP Broten, TP Chang, RSL Ransom, RW Di Salvo, J Nagarathnam, D Forray, C Gluchowski, C Bock, MG
Citation: Ma. Patane et al., Phenylacetamides as selective alpha-1A adrenergic receptor antagonists, BIOORG MED, 10(15), 2000, pp. 1621-1624
Toward the development of alpha(1a) adrenergic receptor antagonists
Authors: Bock, MG Patane, MA
Citation: Mg. Bock et Ma. Patane, Toward the development of alpha(1a) adrenergic receptor antagonists, ANNU REP M, 35, 2000, pp. 221-230
In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha(1A)-adrenoceptor antagonist
Authors: Chang, RSL Chen, TB O'Malley, SS Pettibone, DJ DiSalvo, J Francis, B Bock, MG Freidinger, R Nagarathnam, D Miao, SW Shen, QR Lagu, B Dhar, TGM Tyagarajan, S Marzabadi, MR Wong, WC Gluchowski, C Forray, C
Citation: Rsl. Chang et al., In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha(1A)-adrenoceptor antagonist, EUR J PHARM, 409(3), 2000, pp. 301-312
Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency
Authors: Williams, PD Bock, MG Evans, BE Freidinger, RM Gallicchio, SN Guidotti, MT Jacobson, MA Kuo, MS Levy, MR Lis, EV Michelson, SR Pawluczyk, JM Perlow, DS Pettibone, DJ Quigley, AG Reiss, DR Salvatore, C Stauffer, KJ Woyden, CJ
Citation: Pd. Williams et al., Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency, BIOORG MED, 9(9), 1999, pp. 1311-1316
4-Oxospiro[benzopyran-2,4 '-piperidines] as selective alpha(1a)-adrenergicreceptor antagonists
Authors: Nerenberg, JB Erb, JM Bergman, JM O'Malley, S Chang, RSL Scott, AL Broten, TP Bock, MG
Citation: Jb. Nerenberg et al., 4-Oxospiro[benzopyran-2,4 '-piperidines] as selective alpha(1a)-adrenergicreceptor antagonists, BIOORG MED, 9(2), 1999, pp. 291-294
Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification oflinker and 4-methoxycarbonyl-4-phenylpiperidine moiety
Authors: Dhar, TGM Nagarathnam, D Marzabadi, MR Lagu, B Wong, WC Chiu, G Tyagarajan, S Miao, SW Zhang, FQ Sun, WY Tian, D Shen, QR Zhang, J Wetzel, JM Forray, C Chang, RSL Broten, TP Schorn, TW Chen, TB O'Malley, S Ransom, R Schneck, K Bendesky, R Harrell, CM Vyas, KP Zhang, KY Gilbert, J Pettibone, DJ Patane, MA Bock, MG Freidinger, RM Gluchowski, C
Citation: Tgm. Dhar et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification oflinker and 4-methoxycarbonyl-4-phenylpiperidine moiety, J MED CHEM, 42(23), 1999, pp. 4778-4793
Expedient synthesis of 5-unsubstituted 3,4-dihydropyrimidin-2(1H)-ones.
Authors: Steele, TG Coburn, CA Patane, MA Bock, MG
Citation: Tg. Steele et al., Expedient synthesis of 5-unsubstituted 3,4-dihydropyrimidin-2(1H)-ones., TETRAHEDR L, 39(51), 1998, pp. 9315-9318
Risultati: 1-10 |